SHR-1701 in Combination With Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer
A phase 2 trial of Capecitabine, Oxaliplatin and Retlirafusp alfa in colorectal cancer, run by Suzhou Suncadia Biopharmaceuticals Co., Ltd., now recruiting.
Overview
SHR-1701 in Combination With Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer is a phase 2 interventional study registered as NCT05300269 by Suzhou Suncadia Biopharmaceuticals Co., Ltd., with 73 participants planned, started 2022-07-05 and due to reach its primary completion in 2024-07-31. Interventions recorded: SHR-1701；Capecitabine；Oxaliplatin.
Similar pages
not linked directly; found by shared links- TrialPh1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2 Expression Gastric Cancer
Shares Retlirafusp alfa, Oxaliplatin, Capecitabine, Jiangsu Hengrui Pharmaceuticals and the tag pipeline.
- TrialA Phase Ib/II Trial of HS-20110 Combination Therapies in Advanced Colorectal Cancer Patients.
Shares Oxaliplatin, Capecitabine, Colorectal cancer and the tag pipeline.
- TrialSafety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenocarcinoma
Shares Retlirafusp alfa, Jiangsu Hengrui Pharmaceuticals and the tag pipeline.
- TrialStudy of SHR-8068 Combined With Adebrelimab and Platinum-containing Chemotherapy in the Treatment of Advanced Gastric and Esophageal Cancer
Shares Oxaliplatin, Capecitabine, Jiangsu Hengrui Pharmaceuticals and the tag pipeline.
- TrialA Study Comparing BL-B01D1 With Treatment of Physician's Choice in Patients With Locally Advanced or Metastatic Biliary Tract Cancer After Failure of Platinum-based Chemotherapy(PANKU-BTC01)
Shares Oxaliplatin, Capecitabine and the tag pipeline.
- TrialA Study of BL-M07D1 Versus Physician's Choice of Chemotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Biliary Tract Cancer After Platinum-containing Chemotherapy Failure
Shares Oxaliplatin, Capecitabine and the tag pipeline.
- TrialEvaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal Cancer
Shares Oxaliplatin, Capecitabine and the tag pipeline.
- TrialClinical Study of Adebrelimab Therapy in the Perioperative Treatment of Gastric Cancer or Gastroesophageal Junction Cancer
Shares Oxaliplatin, Jiangsu Hengrui Pharmaceuticals and the tag pipeline.